UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 11, 2026
Sale
Calculated transaction value
$305.47K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 10, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$529.66
Aug 10, 2026
Close before public filing
$529.66
Aug 10, 2026
Return since public filing
-6.15%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 582 shares @ $524.86
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000117
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$6.32M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 10, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $302.84K |
| United Therapeutics Corp UTHR Current | Sale | Aug 10, 2026 | $305.47K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $63.09K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $380.77K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $386.26K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $555.73K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $1.61M |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $339.94K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $244.32K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $208.49K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $153.09K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $275.62K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $100.05K |
| United Therapeutics Corp UTHR | Sale | Aug 10, 2026 | $115.32K |